EA200800343A1 - Ингибиторы jnk для лечения эндометриоза - Google Patents
Ингибиторы jnk для лечения эндометриозаInfo
- Publication number
- EA200800343A1 EA200800343A1 EA200800343A EA200800343A EA200800343A1 EA 200800343 A1 EA200800343 A1 EA 200800343A1 EA 200800343 A EA200800343 A EA 200800343A EA 200800343 A EA200800343 A EA 200800343A EA 200800343 A1 EA200800343 A1 EA 200800343A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- endometriosis
- treatment
- jnk inhibitors
- relates
- jnk inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Настоящее изобретение относится к способу лечения и/или профилактики эндометриоза, включающему введение ингибитора JNK. Ингибитор JNK также может быть введен в комбинации с гормональным супрессором. Изобретение также относится к лечению связанного с эндометриозом бесплодия.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69965805P | 2005-07-15 | 2005-07-15 | |
EP05109447 | 2005-10-11 | ||
PCT/US2006/027455 WO2007011762A2 (en) | 2005-07-15 | 2006-07-12 | Jnk inhibitors for the treatment of endometreosis |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200800343A1 true EA200800343A1 (ru) | 2008-06-30 |
EA016437B1 EA016437B1 (ru) | 2012-05-30 |
Family
ID=35709133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200800343A EA016437B1 (ru) | 2005-07-15 | 2006-07-12 | Ингибитор jnk для лечения эндометриоза и содержащая его фармацевтическая композиция |
Country Status (11)
Country | Link |
---|---|
US (1) | US8592414B2 (ru) |
EP (1) | EP1904181A2 (ru) |
JP (1) | JP2009509916A (ru) |
KR (1) | KR20130087052A (ru) |
AU (1) | AU2006270184B2 (ru) |
BR (1) | BRPI0613042A2 (ru) |
CA (1) | CA2611598A1 (ru) |
EA (1) | EA016437B1 (ru) |
MX (1) | MX2008000663A (ru) |
SG (1) | SG165343A1 (ru) |
WO (1) | WO2007011762A2 (ru) |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3486474T2 (de) | 1983-11-02 | 2000-08-03 | Applied Research Systems | Produkte und Methoden für die Herstellung einer heterodimerer menschlicher LH mit einem Met42 Val55 alpha Untereinheit |
US4923805A (en) | 1983-11-02 | 1990-05-08 | Integrated Genetics, Inc. | Fsh |
IT1206302B (it) | 1987-06-26 | 1989-04-14 | Serono Cesare Ist Ricerca | Ormone follicolo-stimolante urinario |
US4988679A (en) | 1989-01-03 | 1991-01-29 | Leonard Chavkin | Liquid sustained release composition |
IE82916B1 (en) | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
RU2166955C2 (ru) | 1991-01-18 | 2001-05-20 | Эмген Инк. | Способ лечения и профилактики заболеваний, обусловленных повышением уровня фактора, вызывающего некроз опухолевых клеток |
US5433951A (en) | 1993-10-13 | 1995-07-18 | Bristol-Myers Squibb Company | Sustained release formulation containing captopril and method |
EP0727406B1 (de) | 1995-02-16 | 2001-09-05 | MERCK PATENT GmbH | Vinylenverbindungen und flüssigkristallines Medium |
FR2762514B1 (fr) | 1997-04-29 | 1999-10-22 | Sanofi Sa | Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation |
SE9801474D0 (sv) | 1998-04-27 | 1998-04-27 | Active Biotech Ab | Quinoline Derivatives |
TW591026B (en) | 1998-06-23 | 2004-06-11 | Upjohn Co | Inhibitors of alpha4beta1 mediated cell adhesion |
AU770060B2 (en) | 1998-12-17 | 2004-02-12 | F. Hoffmann-La Roche Ag | 4,5-azolo-oxindoles |
CN1147486C (zh) | 1998-12-17 | 2004-04-28 | 霍夫曼-拉罗奇有限公司 | 4-和5-炔基羟吲哚和4-和5-烯基羟吲哚 |
KR20010101266A (ko) * | 1998-12-17 | 2001-11-14 | 프리돌린 클라우스너, 롤란드 비. 보레르 | Jnk 단백질 키나제의 억제제로서의 4-아릴옥신돌 |
ATE425142T1 (de) | 1999-04-23 | 2009-03-15 | Vertex Pharma | Inhibitoren von c-jun n-terminal kinasen (jnk) |
AU5316900A (en) | 1999-06-03 | 2000-12-28 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-jun n-terminal kinases (jnk) |
AU6909600A (en) | 1999-08-13 | 2001-03-13 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
KR100835700B1 (ko) | 1999-08-19 | 2008-06-09 | 시그널 파머슈티컬스 인크 | Jnk억제제로서의 피라졸로안트론과 그 유도체 및 이를 함유하는 조성물 |
EP1088815A1 (en) | 1999-09-28 | 2001-04-04 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonyl amino acid derivatives |
EP1088821A1 (en) | 1999-09-28 | 2001-04-04 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives |
EP1088822A1 (en) | 1999-09-28 | 2001-04-04 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonyl hydrazide derivatives |
US20020115689A1 (en) | 1999-12-21 | 2002-08-22 | Joanne Waldstreicher | Combination therapy for treating neurodegenerative disease |
EP1110957A1 (en) * | 1999-12-24 | 2001-06-27 | Applied Research Systems ARS Holding N.V. | Benzazole derivatives and their use as JNK modulators |
BR0108685A (pt) * | 2000-02-25 | 2003-12-30 | Procrea Biosciences Inc | Marcadores relacionados com endometriose |
EP1193267A1 (en) | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein JunKinases |
EP1193268A1 (en) | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
US6399626B1 (en) | 2000-10-02 | 2002-06-04 | Wyeth | Hydroxyesters of 7-desmethylrapamycin |
US20030134836A1 (en) | 2001-01-12 | 2003-07-17 | Amgen Inc. | Substituted arylamine derivatives and methods of use |
US7115617B2 (en) | 2001-08-22 | 2006-10-03 | Amgen Inc. | Amino-substituted pyrimidinyl derivatives and methods of use |
ATE340572T1 (de) | 2001-12-07 | 2006-10-15 | Applied Research Systems | Benzazole derivate zur behandlung von scleroderma |
US7803749B2 (en) * | 2002-01-09 | 2010-09-28 | Xigen Sa | Peptide inhibitors of MKK7 kinase binding to insulin binding proteins |
GB0204159D0 (en) | 2002-02-22 | 2002-04-10 | British Biotech Pharm | Metalloproteinase inhibitors |
NZ535349A (en) | 2002-03-08 | 2007-01-26 | Signal Pharm Inc | JNK inhibitors with chemotherapeutic agents in a combination therapy for treating or preventing cancer and other proliferative disorders in refractory patients in particular |
EA009682B1 (ru) | 2002-04-25 | 2008-02-28 | Апплайд Резеч Системз Арс Холдинг Н. В. | Пиперазинбензотиазолы, используемые в качестве средств для лечения церебральных ишемических расстройств или расстройств цнс |
TW200410631A (en) | 2002-09-25 | 2004-07-01 | Meiji Seika Kaisha | Slow-releasable pesticide granules |
TWI291467B (en) | 2002-11-13 | 2007-12-21 | Millennium Pharm Inc | CCR1 antagonists and methods of use therefor |
WO2004082665A1 (ja) | 2003-03-17 | 2004-09-30 | Takeda Pharmaceutical Company Limited | 放出制御組成物 |
DE602004010178T2 (de) | 2003-09-12 | 2008-09-11 | Laboratoires Serono S.A., Coinsins | Benzothiazol-derivate zur behandlung von diabetes |
US20070079629A1 (en) | 2003-10-30 | 2007-04-12 | Laboratories Serono S.A. | Process and apparatus for cooling and atomizing liquid or pasty-like substances |
RU2253489C1 (ru) * | 2004-04-07 | 2005-06-10 | Научный центр акушерства, гинекологии и перинатологии РАМН | Способ лечения бесплодия у женщин с наружным генитальным эндометриозом |
DK1812072T3 (da) * | 2004-11-17 | 2008-12-01 | Ares Trading Sa | Benzothiazol-præparat og anvendelse deraf |
US7838522B2 (en) * | 2004-11-17 | 2010-11-23 | Ares Trading S.A. | Benzothiazole formulations and use thereof |
-
2006
- 2006-07-11 BR BRPI0613042-9A patent/BRPI0613042A2/pt not_active IP Right Cessation
- 2006-07-12 JP JP2008521654A patent/JP2009509916A/ja not_active Withdrawn
- 2006-07-12 KR KR1020137016652A patent/KR20130087052A/ko not_active Application Discontinuation
- 2006-07-12 AU AU2006270184A patent/AU2006270184B2/en not_active Ceased
- 2006-07-12 CA CA002611598A patent/CA2611598A1/en not_active Abandoned
- 2006-07-12 US US11/988,572 patent/US8592414B2/en not_active Expired - Fee Related
- 2006-07-12 EA EA200800343A patent/EA016437B1/ru not_active IP Right Cessation
- 2006-07-12 MX MX2008000663A patent/MX2008000663A/es active IP Right Grant
- 2006-07-12 SG SG201006416-0A patent/SG165343A1/en unknown
- 2006-07-12 WO PCT/US2006/027455 patent/WO2007011762A2/en active Application Filing
- 2006-07-12 EP EP06787369A patent/EP1904181A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2007011762A2 (en) | 2007-01-25 |
AU2006270184B2 (en) | 2011-09-29 |
SG165343A1 (en) | 2010-10-28 |
WO2007011762A8 (en) | 2007-08-02 |
EP1904181A2 (en) | 2008-04-02 |
JP2009509916A (ja) | 2009-03-12 |
EA016437B1 (ru) | 2012-05-30 |
CA2611598A1 (en) | 2007-01-25 |
US8592414B2 (en) | 2013-11-26 |
WO2007011762A3 (en) | 2007-04-05 |
BRPI0613042A2 (pt) | 2010-12-14 |
KR20130087052A (ko) | 2013-08-05 |
US20090176761A1 (en) | 2009-07-09 |
MX2008000663A (es) | 2008-03-13 |
AU2006270184A1 (en) | 2007-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200800755A1 (ru) | Ikk ингибиторы, предназначенные для лечения эндометриоза | |
EA200800766A1 (ru) | Ингибиторы pi3k для лечения эндометриоза | |
EA200970932A1 (ru) | Способы лечения с применением пиридопиримидиноновых ингибиторов pi3k альфа | |
EA201690745A1 (ru) | Способы лечения и предотвращения болезни "трансплантат против хозяина" | |
EA201070740A1 (ru) | Способ лечения перелома кости антителами против склеростина | |
NO20083202L (no) | ANG2- og VEFG-inhibitorkombinasjoner | |
BRPI0508254A (pt) | métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos | |
WO2006099261A3 (en) | Potent and specific immunoproteasome inhibitors | |
SG157365A1 (en) | Compositions and methods for treating neoplastic diseases | |
EA201270184A1 (ru) | Лечение расстройств печени ингибиторами pi3k | |
MX366119B (es) | Uso de un agente inhibidor de masp-2 para el tratamiento de condiciones renales mediadas por complemento dependiente de la masp-2. | |
EA200870029A1 (ru) | Способ применения антагонистов il-6 с ингибиторами протеасом | |
EA200870425A1 (ru) | Применение агонистов рецептора grp119 для повышения костной массы и для лечения остеопороза и связанной с ними комбинированной терапии | |
MX2008011633A (es) | Aminoquinolonas como inhibidores de gsk-3. | |
CL2008001782A1 (es) | Uso de una composicion que comprende un compuesto derivado de heterociclo para tratar o prevenir la perdida de flujo intestinal; composicion que comprende dicho compusto; y kit que comprende la composicion. | |
JO3358B1 (ar) | معالجات حساسية العيون | |
EA201100609A1 (ru) | Способы лечения воспаления | |
BRPI0408902A (pt) | composições de inibidores seletivos da ciclooxigenase-2 e agonistas de 5-ht 1b/1d para o tratamento e a prevenção de enxaqueca | |
EA200802412A1 (ru) | Терапевтические комбинации для сопровождающихся болью медицинских состояний | |
NO20065297L (no) | Anvendelse av GPCR54 ligander til behandling av infertilitet | |
ATE531721T1 (de) | Cyanoaminochinolone als gsk-3-inhibitoren | |
NO20065859L (no) | Bruk av IL-17 behandlingen av fertilitetsrelaterte lidelser | |
CL2009000803A1 (es) | Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada | |
EA200970164A1 (ru) | Ингибиторы каспазы на основе пиридазинонового каркаса | |
UA96736C2 (ru) | Ингибиторы pi3k для лечения эндометриоза |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |